Milen I. Georgiev

Bulgarian Academy of Sciences, Bulgaria

Editor in chief, eFood

Associate Editor, Phytomedicine

Associate Editor, Food and Chemical Toxicology

Scientific editor, Food Frontiers

Phytochemistry, Biotechnology Letters, Chinese Medicine,

 

Anti-obesity potential of plant natural compounds: from in vitro (human SGBS adipocytes) to in vivo (Caenorhabditis elegans) studies

 

Prof. Dr. Milen I. Georgiev is heading a Lab of Metabolomics@Institute of Microbiology, Bulgarian Academy of Sciences. He has 20 years of experience in natural products field and has published in excess of 170 papers (i.a., Nature Reviews Drug Discovery, Genome Biology, Trends in Biotechnology, Plant Physiology and Plant Biotechnology Journal, among others). He has delivered 50+ invited lectures in 20 different countries. Milen holds several grants from the NSF of Bulgaria, Romania and framework programmes of the European Union (incl. H2020 –PlantaSYST project, well-funded with 30 million Euro).

In 2020 and 2021, he was listed among top 2% in the Stanford University worldwide citation ranking of all scientists and scientific disciplines. Milen is a recipient of Pythagoras award for outstanding scientist by the Bulgarian Ministry of Education and Science (2011, 2015 and 2020), as at present the only scientist in

Bulgaria to have won three times.

Milen serves as an Editor, Associate Editor and Editorial Board member of dozen journals in biotechnology and natural products fields, incl. Phytomedicine, Food and Chemical Toxicology, Phytochemistry, Biotechnology Letters, Chinese Medicine, eFood, Food Frontiers, International Journal of Molecular Sciences, Frontiers in Pharmacology, among others. Serving as a chairman he has established the International Conference on Natural Products Utilization: from Plants to Pharmacy Shelf (ICNPU), which had four issues so far. The latest ICNPU edition attracted attention of 330+ participants from 50 different countries (www.icnpu.com/2019).

His current research focuses on 1) biosynthesis of fine molecules and development of biotech tools for their sustainable mass production, 2) metabolomics and comprehensive metabolite profiling and 3) molecular pharmacology (with particular focus on obesity and inflammation).